Protect Your Portfolio Against Market Uncertainty
- Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
- Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
BONESUPPORT HOLDING AB ( (SE:BONEX) ) has issued an update.
BONESUPPORT announces a leadership transition with Emil Billbäck stepping down as CEO to become a Senior Advisor, while Torbjörn Sköld will assume the CEO role starting September 1, 2025. This change is expected to leverage Sköld’s extensive MedTech experience to further the company’s growth and innovation in transforming bone injury care, while Billbäck’s continued involvement ensures strategic continuity.
More about BONESUPPORT HOLDING AB
BONESUPPORT is a prominent company in the orthobiologics industry, specializing in innovative injectable bio-ceramic bone graft substitutes that remodel to the patient’s own bone and can elute drugs. Based in Lund, Sweden, BONESUPPORT focuses on advancing bone injury management through its patented technology platform and is involved in several clinical studies to demonstrate the clinical and health economic benefits of its products.
YTD Price Performance: -20.24%
Average Trading Volume: 361
Technical Sentiment Signal: Sell
Current Market Cap: $2.16B
Find detailed analytics on BONEX stock on TipRanks’ Stock Analysis page.